Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1798]

Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer...

Dr Sara Hurvitz - University of California, Los Angeles, USA

Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgroups ( Dr Sara Hurvitz - University of California, Los Angeles, USA )

WHO and St. Jude Children’s research hospital to dramatically increase global...

Dr Andre Llbawi - World Health Organization (WHO) Global Childhood Cancer...

WHO and St. Jude Children’s research hospital to dramatically increase global access to childhood cancer medicine ( Dr Andre Llbawi - World Health Organization (WHO) Global Childhood Cancer Initiative )

Long-term OS benefit with oral azacitidine for acute myeloid leukaemia in first...

Prof Andrew Wei - Monash University, Melbourne, Australia

Long-term OS benefit with oral azacitidine for acute myeloid leukaemia in first remission after intensive chemo ( Prof Andrew Wei - Monash University, Melbourne, Australia )

Allogeneic haematopoietic cell transplantation in adults with Ph-like ALL

Dr Ibrahim Aldoss - City of Hope, Duarte, USA

Allogeneic haematopoietic cell transplantation in adults with Ph-like ALL ( Dr Ibrahim Aldoss - City of Hope, Duarte, USA )

Ten-day decitabine with venetoclax in acute myeloid leukaemia: Updated outcomes...

Dr Abhishek Maiti - The University of Texas MD Anderson Cancer Center, Houston...

Ten-day decitabine with venetoclax in acute myeloid leukaemia: Updated outcomes across genomic subgroups ( Dr Abhishek Maiti - The University of Texas MD Anderson Cancer Center, Houston, USA )

Axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory...

Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA

$Axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory large B-cell lymphoma ( Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA )$

Dara-CVRd, V-ASCT and Dara-Vrd Consolidation in UHiR NDMM and pPCL compared...

Dr Martin Kaiser - The Institute of Cancer Research, London UK

Dara-CVRd, V-ASCT and Dara-Vrd Consolidation in UHiR NDMM and pPCL compared with myeloma XI/XI+ Trial treatment for Uhir MM ( Dr Martin Kaiser - The Institute of Cancer Research, London UK )

Monoclonal antibody-based quadruplet therapy, AHCT and MRD response-adapted...

Prof Luciano Costa - University of Alabama at Birmingham, Birmingham, USA

Monoclonal antibody-based quadruplet therapy, AHCT and MRD response-adapted consolidation therapy gives highest rate of MRD negativity in NDMM ( Prof Luciano Costa - University of Alabama at Birmingham, Birmingham, USA )

Lisocabtagene maraleucel demonstrates improvement over standard of care in 2L...

Dr Manali Kamdar - The University of Colorado Anschutz Medical Campus, Aurora...

Lisocabtagene maraleucel demonstrates improvement over standard of care in 2L LBCL ( Dr Manali Kamdar - The University of Colorado Anschutz Medical Campus, Aurora, USA )

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Treating late relapse of paediatric ALL

Dr Arend von Stackelberg - Charité Universitätsmedizin, Berlin, Germany

Treating late relapse of paediatric ALL ( Dr Arend von Stackelberg - Charité Universitätsmedizin, Berlin, Germany )

Cancer drug policy and access in LMICs

Dr Bishal Gyawali - Queen's University, Kingston, Canada

Cancer drug policy and access in LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

More from ecancer